Scientists have developed a peptide that can stop alpha-synuclein, the protein responsible for Parkinson’s disease and certain dementias, from misfolding into its dangerous form. Testing in the lab and in animals showed that this peptide stabilized the protein and led to better motor skills. This research highlights the potential of targeted drug design to address brain disorders that have been difficult to treat.
find the original post here https://www.sciencedaily.com/releases/2025/10/251008030949.htm
Leave a Reply to ein binance Konto er”offnenCancel reply